Index. Note: Page numbers followed by f and t refer to figures and tables respectively
|
|
- Anthony Fleming
- 6 years ago
- Views:
Transcription
1 Index Note: Page numbers followed by f and t refer to figures and tables respectively A Abobotulinumtoxin A, 397 Acid skin, 153 Acne, Acne inversa. See Hidradenitis suppurativa (HS) Acne keloidalis nuchae (AKN), 238, 239 clinical features, epidemiology, 365 pathophysiology, 365 treatment, Acne scars, Acne vulgaris, 300 acne scarring, 114 azelaic acid, 112 benzoyl peroxide, 112 Caucasian skin, 104 depigmentation, 114 doxycycline and minocycline, 113 gold standard therapy, 113 hydroquinone, hyperpigmentation, 103 post-inflammatory, 104 hypopigmentation, 114 isotretinoin (13-cis-retinoid acid), 113 pathogenesis of, 104 pomade acne, 105 prominent feature of, 104 retinoids, 106 steroid acne, 106 topical antimicrobials, 112 treatment of, 106 web-based survey, 104 Acneiform eruptions acne vulgaris, 300 periorificial dermatitis, 300 Acquired idiopathic pattern facial pigmentation (AIPFP), 79 Acquired immune deficiency syndrome (AIDS), 95 Acquired trichorrhexis nodosa (ATN), 349 Acral lentiginous melanoma (ALM), 266, 267f Actinic lichen planus, 136 Actinic prurigo, 96 Acute cutaneous lupus erythematosus (ACLE), 164 Adalimumab, 372 Adapalene gel, 106 Adjunctive therapy, 181 Adnexal disorders acne keloidalis nuchae clinical features, epidemiology, 365 pathophysiology, 365 treatment, dissecting cellulitis clinical features, epidemiology, 369 pathophysiology, 369 treatment, hidradenitis suppurativa clinical features, epidemiology, pathophysiology, 373 treatment, pseudofolliculitis barbae clinical features, epidemiology, 359 pathophysiology, 360 treatment, African American (AA) patients, 300 atopic dermatitis, 295 Alexandrite, Alezzandrini syndrome, 223 Allergic contact dermatitis (ACD), 297 Allium cepa, 247 Alopecia, Springer International Publishing AG 2017 N.A. Vashi and H.I. Maibach (eds.), Dermatoanthropology of Ethnic Skin and Hair, DOI /
2 480 Index Alopecia areata, 223 Alpha-hydroxy acids (AHAs) glycolic acid, lactic acid, 441 mandelic acid, 441 phytic acid, pyruvic acid, 442 Amalgam tattoo, 90 American Academy of Dermatology (AAD), 58 American College of Rheumatology (ACR), 163 Androgen receptor (AR) gene, 337 Androgenetic alopecia (AGA), 335, 337, 338 Angiotensin converting enzyme (ACE), 188 Anti-centromere antibody (ACA), 176 Anti-desmogleins, 98 Antimalarials, 181 Antinuclear antibodies (ANAs), 116, 167 Apocrine glands, 43 Arbutin, 425 Ascorbic acid, 425 Atopic dermatitis (AD), clinical presentation, epidemiology, histopathology, 131 pathophysiology of, 130 treatment, Atopic dirty neck, 304 Azelaic acid, acne, 112 rosacea, 117 B Basal cell carcinoma (BCC), 258 clinical presentation, 263 pathogenesis, 262 pathology, treatment, 264 Becker s nevus, 291 Behҫet s disease, Benzoyl peroxide (BPO), 112 Beta-hydroxy acids b-lipohydroxy acid, salicylic acid, Biopsies, 80, 148 melasma lesions, 202 Birthmarks dermal melanocytosis, café-au-lait macules, 288 patterned pigmentation, linear nevoid hypomelanosis vs. LWNH, 289 pigmentary demarcation lines, 289 transient infantile patterned hyperpigmentation, 289 Black dot, 146 Black gums, 79 Black skin, 28, 29 Bleomycin, 247 Body surface area (BSA), 294 Botulinum toxin, 397 Brimonidine gel, 122 Buccal mucosa, 88 Butterfly rash, 164 C Café-au-lait macules (CALMs), 288 Campbell-De Morgan spot. See Cherry angioma Caveolin-1, 173 Central centrifugal cicatricial alopecia (CCCA), 332 clinical, 341 differential diagnoses, 342 etiology of, 340 hot comb alopecia, 340 pathogenesis, 340 systemic anti-inflammatory agents, 342 treatment of, 342 Chemical peels dermatologic disorders, 437, 438t peeling agents alpha-hydroxy acids, beta-hydroxy acids, Jessner s solution, retinoids, 445 trichloroacetic acid, 444 post-treatment, 445 Chemical reconstruction of skin scars (CROSS), 411 Cherry angioma, 393 Chloasma. See Melasma Chronic cutaneous lupus erythematosus (CCLE), 164 (discoid) lupus erythematosus (DLE), Chronic hair infection, 145 Circumscribed morphea, 182 Clear cell papulosis, Clindamycin, 375 Complementary and alternative medicine (CAM), 467, Complex aphthosis, 97 Confetti leukoderma, 422 Confluent and reticulated papillomatosis (CARP), 293 Congenital melanocytic nevi (CMN), 291
3 Index 481 Corneocytes, 64 Corticosteroids, 98 Cosmetic concerns acne scars, dermatosis papulosa nigra, 407 hyperpigmentation, photoaging, 409 prominent mandible, seborrheic dermatitis, 412 unwanted hair, varicosities, Cryotherapy, 217 Cultural competency, Cultural considerations dermatology, cultural competency in, ethnic and racial minority populations complementary and alternative medicine, use of, low health literacy and limited English proficiency, socioeconomic and health disparities, medication adherence, importance of, 469 Cushing s syndrome, 243 Cutaneous B-cell lymphoma (CBCL), 270, 272 Cutaneous lupus erythematosus (CLE), 161 histologic features of, 167 management of, 171 Cutaneous lymphoma B-cell lymphoma (CBCL), 272 mycosis fungoides, 270, 271 hypopigmented, 271, 272f non-hodgkin lymphomas, 270 T-cell lymphoma (CTCL), 270 Cutaneous T-cell lymphoma (CTCL), 221, 270 Cyclophosphamide, 177 Cytobrush method, 147 D Dark-haired populations, 318 Darker skin UVA, biological effects of, 51 UVB, biological effects of, Delayed tanning (DT), 55 Demodex folliculorum, 122 Dendritic cells, 36 Dermal fibrosis, 233 Dermal melanocytosis, blue nevus, 288 Mongolian spots, 286 nevus of Ito, 287 nevus of Ota, 287 Dermal epidermal junction (DEJ), Dermatitis allergic contact dermatitis, 297 atopic dermatitis, seborrheic dermatitis, Dermatofibrosarcoma protuberans (DFSP), Dermatology Life Quality Index (DLQI), 14 Dermatomyositis (DM) clinical presentation, diagnosis of, 179 epidemiology, 178 histology, 180 pathogenesis, prognosis and mortality, 180 treatment, Dermatophytosis, 145 Dermatosis papulosa nigra (DPN), 392, 407 Dermoscopy, 148, 156 Diffuse large B-cell lymphoma-leg type (DLBCL), 272 Diffuse pustular, 146 Diffuse scale, 146 Dihydrotestosterone (DHT), 44 Dihydroxyphenylalanine (DOPA), 421 Diltiazem, 208 Direct immunofluorescence (DIF), 167 Discoid lesions, 162 Discoid lupus erythematosus (DLE), 164 Dissecting cellulitis (DC), 347 clinical features, epidemiology, 369 pathophysiology, 369 treatment, Doxycycline, 113, 123 D-penicillamine, 177 Drug-induced hyperpigmentation, 91, 92f diagnosis and clinical presentation, etiology, 208 histology, 208 management, 209 Dyschromia, 417 E Eccrine glands, 43 Eczema. See Atopic dermatitis (AD) Electrodessication, 393 Electromagnetic spectrum photodermatoses categories, 56 medical treatment of, 57 photoaggravated dermatoses, 56, 57t phytophotodermatitis, 56 solar radiation, 49, 50f
4 482 Index Electromagnetic spectrum (cont.) sun protection, 58 ultraviolet radiation biological effects of, clinical effects, visible light biological effects of, 54 erythema and pigmentation, 56 Epidermis keratinocytes and corneocytes, 64 Langerhans cells, 64 Merkel cells, 64 transepidermal water loss, 63 unique architecture, layers of, 63 Erythema, 130 Erythema dyschromicum perstans (EDP), 204 diagnosis and clinical presentation, 205 etiology, histology, 206 management, 206 Ethnic hair biochemical diversity, hair care practices chemical relaxers, side effects of, 333 hair restructuring techniques, 332 hairstyles, 332 hot combing, 332 Ethnic populations, skin structure and function in cutaneous appendages apocrine glands, 43 eccrine glands, 43 sebaceous glands, 44 dermal epidermal junction, dermis, epidermis, hair follicles, melanin, melanocytes, melanosomes, 40 stratum corneum black and white skin, differences of, 36, 37t ceramides, 38 compartments, 36 lipid composition of, 36 lipid-rich membrane, 36 skin irritation, 37 skin ph, 38 transepidermal water loss, water content, 38 skin pigmentation, 40 Ethnic skin acne, treatment of, 106 chemical peels in.(see Chemical peels) laser treatment. (See Laser treatment) Ethnic skin, biophysical properties of barrier function stratum corneum, 27 transepidermal water loss, 28 biophysical parameters, irritation, 30 skin aging, Exophiala werneckii, 155 F Facial Afro-Caribbean childhood eruption (FACE), 117 Favus, 145, 146 Female pattern hair loss (FPHL), 335, 336, 336f Fibroblast, 42 Fitzpatrick skin types (FST), 41, 115, 422 Flavonoids, 93 Fluconazole, Fluorouracil (5-FU), 247 Fluticasone, 131 Food and Drug Administration (FDA), 117, 338 Forced vital capacity (FVC), 188 Free fatty acids (FFAs), 68 Friction hypermelanosis, 292 Frontal fibrosing alopecia, 349 Futcher s lines, 289 G Gastrointestinal tract (GIT), 175 Generalized morphea, 182 Genitals, melanotic macules of, 80 Glucose-6-phosphate dehydrogenase (G6PD) deficiency, 112 Glutathione (GSH), 430 Glycolic acid (GA), 424, Gold standard therapy, 113 Gottron s papules, 179 Granular layer, 36 Granulomatous rosacea, 116 Gray patch, 146 Griseofulvin, 149 Guttate psoriasis, 133 H Hair disease, alopecia, Hair disorders alopecia patient, hair shaft disorders, inflammatory scalp conditions, nonscarring alopecia
5 Index 483 androgenetic alopecia, 335, 337, 338 anti-androgenic agents, role of, 339 FDA-approved medication, 338 female pattern hair loss, 336, 336f histopathologic examination, 336 laser phototherapy, 339 male pattern hair loss, 335 platelet-rich plasma, 339 pull test, 337 piedra, 302 scarring alopecias central centrifugal cicatricial alopecia, chronic cutaneous DLE, lichen planopilaris, 349 neutrophilic scarring alopecias, traction alopecia, tinea capitis, trichorrhexis nodosa, 301 Hair fiber pigmentation, Hair loss, evolution of, 1 Hair shaft disorders, Health literacy, 470 Health-related quality of life (HRQL), Heliobacter pylori infection, 97 Heliotrope rash, 179 Hepatotoxicity, 154 Herpetiform ulcers (HU), 97 Hidradenitis suppurativa (HS), 368 clinical features, epidemiology, pathophysiology, 373 treatment, HLA-Cw6 antigen, 133 Homeostasis, 67 Human herpes virus-8 (HHV-8), 95, 273 Human immunodeficiency virus (HIV), 95 Human leukocyte antigen (HLA), 96, 162 Human papilloma virus (HPV), 94 Human scalp hair evolution of, 319 genetic basis of, hair fibers geometry and curvature, 322 moisture content of, 323 pigmentation, hair grooming practices, populations, hair growth parameters, overview of, phenotypes, scalp microbiome, 324 tensile properties and combability, 323 Hydroquinone (HQ), 155, Hydroxychloroquine, 171 Hyperpigmentation causes of, 197 chemical peels, 427 cosmetic concerns, drug-induced hyperpigmentation diagnosis and clinical presentation, etiology, 208 histology, 208 management, 209 erythema dyschromicum perstans diagnosis and clinical presentation, 205 etiology, histology, 206 management, 206 evaluation of, intravenous agents, lasers, lichen planus pigmentosus diagnosis and clinical presentation, 204 etiology, 204 histology, 204 management, melasma diagnosis and clinical presentation, 201 etiology, 201 histology, management, 202 metabolic causes of, microdermabrasion, microneedling, 428 oral agents botanical agents, 430 emerging oral treatments, 430 tranexamic acid, 429 post-inflammatory hyperpigmentation diagnosis and clinical presentation, 198 etiology, histology, 199 management, 199 topical therapies.(see Topical therapies, hyperpigmentation) Hypertrophic scars (HTS) clinical presentation, cryotherapy, 245 genetics, histology, 237 vs. keloid, Nd:YAG, 246 onion extract, 247 pathophysiology, 238 PDL treatment,
6 484 Index Hypertrophic scars (HTS) (cont.) predisposing factors, pressure dressings, 241 variants acne keloidalis nuchae, 239 pseudofolliculitis barbae, Hypodermis, 43 Hypopigmentation and depigmentation, disorders of idiopathic guttate hypomelanosis, mycosis fungoides, 221 oculocutaneous albinism, pityriasis alba, piebaldism, 223 PIHypo, progressive macular hypomelanosis, tinea versicolor, vitiligo, Hypothalamic pituitary adrenal (HPA), 131 I Idiopathic eruptive macular pigmentation, 292 Idiopathic guttate hypomelanosis (IGH) age-associated pigmentary changes, 395 hypopigmentation and depigmentation, disorders of, Idiopathic inflammatory myositis, 177 Immediate pigment darkening (IPD), 54 Incobotulinumtoxin A, 398 Individual typology angle (ITA), 53 Infantile acropustulosis (IA), 303 Inflammatory disorders atopic dermatitis clinical presentation, epidemiology, histopathology, 131 pathophysiology of, 130 treatment, lichen planus clinical features, epidemiology, 136 histopathology, pathogenesis, 136 treatment, 139 psoriasis clinical manifestations, epidemiology, 132 histopathology, 135 pathophysiology, 133 treatment, 135 Inflammatory variants, 147 Infliximab, 372 Intense pulse light (IPL), 202, 399, 455, Intermittent CLE (ICLE), 167 Intracellular adhesion molecule 1 (ICAM-1), 219 Intralesional corticosteroids, 376 Intraoral lesions, 88 Intravenous cyclophosphamide (IVC), 172 Irritant contact dermatitis (ICD), 106 Irritation, 30 Isotretinoin, 372 Itraconazole, 155 Ivermectin, 122 J Jessner s solution, K Kaposi s sarcoma (KS), AIDS-related, 273 classic and endemic, 273 clinical presentation of, 272 HHV-8 infection, 273 historical, transplantation-related, 273 treatment of, 275 types, 273 Keloid scars, 20 clinical presentation, epidemiology, 234 genetics, histology, 237 hypertrophic scars vs., pathophysiology, 238 predisposing factors, primary prevention, 240 secondary prevention ear keloids, pressure dressings, 241 radiation, silicone gel sheets, treatment botulinum toxin type A, 248 calcium antagonists, 248 chemotherapeutics, CO 2 treatment, 246 corticosteroids, 243 cryotherapy, 245 Nd:YAG, 246 onion extract, 247 PDL treatment, surgical excision, variants
7 Index 485 acne keloidalis nuchae, 239 pseudofolliculitis barbae, Keratin-associated proteins (KAPs), 321 Keratinocytes, 35, 64, 151, 198 Kerion, 146 Ketoconazole, 150, 216 Kojic acid, L Lactic acid, 441 Langerhans cells, 36 Laser toning, 455 Laser treatment consultation, Nd:YAG, fractional photothermolysis, intense pulse light, PDL treatment, post-treatment, principles, 449, 452 skin of color, special considerations in, 452 types of, 449, t alexandrite, ruby laser, Leukoedema, Lichen planopilaris, 349 Lichen planus (LP), 299 clinical features, epidemiology, 136 histopathology, pathogenesis, 136 treatment, 139 Lichen planus actinicus, 136 Lichen planus pigmentosus (LPP) diagnosis and clinical presentation, 204 etiology, 204 histology, 204 management, Licorice, Limited English proficiency (LEP), Linear and whorled nevoid hypermelanosis (LWNH), 289 Linear morphea, 182 Linoleic acid, 68 Lipid milieu, 67 b-lipohydroxy acid (LHA), Lipoxygenases, 151 Liquor carbonis detergents (LCD), 218 Localized scleroderma. See Morphea Longitudinal melanonychia, 81 Lupus band test, 167 Lymph nodes (LN), 273 M Major histocompatibility (MHC), 238 Malar rash, 162 Malassezia genus, 150 Malassezia globosa, 151 Male pattern hair loss (MPHL), 335 Mandelic acid, 441 Mask of pregnancy, 200 Mast cells, 42 Maturational hyperpigmentation, 393 Medication adherence, 469 Medulla, 321 Melanin, 218, 219 Melanin dust, 4 Melanoacanthosis, 89 Melanocortin 1 receptor (MC1R), 2, 52 Melanocytes, 215, 216, 217 Melanocytic nevi, 90 Melanocytopenic, 215, 216 Melanoma clinical presentation, incidence, 264 pathogenesis and risk factors, 265 treatment and prognosis, Melanopenic, 215, 216 Melasma, diagnosis and clinical presentation, 201 etiology, 201 histology, management, 202 Melasma Area Severity Index (MASI), 440 Mequinol, 424 Merkel cell carcinoma (MCC), Merkel cell polyomavirus (MCPyV), 277 Merkel cells, 36 Methotrexate, 177, Methoxypsoralen (8-MOP), Methyltetrahydrofolate (5-MTHF), 3 Metronidazole, 117 Microdermabrasion, Microneedling, 428 Microscopic epidermal necrotic debris (MEND), 459 Microsporum audouinii, 145 Microsporum canis, 145 Minimal erythema dose (MED), 40, 53 Minimal melanogenic dose (MMD), 55 Minocycline, 113, 177, 376 Minor aphthous ulcers (MiAU), 97 Mitomycin, 247 Mixed morphea, 182 Morphea clinical presentation,
8 486 Index Morphea (cont.) histology, 182 prevalence in, 181 treatment, 183 Mucosal lesions mucosal areas, physiologic variation in, nonpigmented oral lesions actinic prurigo, 96 Kaposi s sarcoma, leukoedema, squamous cell carcinoma, submucous fibrosis, 93 oral pigmented lesions amalgam tattoo, 90 drug-induced hyperpigmentation, 91, 92f melanoacanthosis, 89 melanocytic nevi, 90 oral mucosal melanoma, 91 oral melanotic macules and lentigines, 88 post-inflammatory hyperpigmentation, 92 smoker s melanosis, oral ulcers Behҫet s disease, pemphigus vulgaris, recurrent aphthous stomatitis, 97 Multisystem inflammatory disorder, 183 Mycophenolate mofetil (MMF), 172 Mycosel, 147 Mycosis fungoides (MF), 221, 270 Myofibroblasts, 237 N N-acetyl glucosamine (NAG), 426 Naked skin, evolution of, 1 3 disadvantages, 2 folate, photodegradation of, 3 hair loss, 1 2 MC1R locus, 2 National Ambulatory Medical Care Survey (NAMCS), 114, 372 Natural moisturizing factor (NMF), Neurocutaneous melanosis (NCM), 291 Neurotoxin injection, 413 Neutrophilic scarring alopecias, Niacinamide, 426 Nodulocystic acne, 1046 Non-Hodgkin lymphomas (NHL), 270 Non-melanoma skin cancer (NMSC), 257, 258 Nonpigmented oral lesions actinic prurigo, 96 Kaposi s sarcoma, leukoedema, squamous cell carcinoma, submucous fibrosis, 93 Nonpustular psoriasis, 133 Nonscarring alopecia androgenetic alopecia, 335, 337, 338 anti-androgenic agents, role of, 339 FDA-approved medication, 338 female pattern hair loss, 336, 336f histopathologic examination, 336 laser phototherapy, 339 male pattern hair loss, 335 platelet-rich plasma, 339 pull test, 337 O Oculocutaneous albinism (OCA), Onabotulinumtoxin A, 397 Oral cancer, 94 Oral cavity, 87 Oral doxycycline, 376 Oral melanoacanthosis (OM), 89 Oral melanocytic nevi (OMN), 90 Oral mucosal hyperpigmentation mucosal melanosis, oral melanotic macules, 80 treatment of, 80 Oral mucosal melanoma (OMM), 91 Oral pigmented lesions amalgam tattoo, 90 drug-induced hyperpigmentation, 91, 92f melanoacanthosis, 89 melanocytic nevi, 90 oral mucosal melanoma, 91 oral melanotic macules and lentigines, 88 post-inflammatory hyperpigmentation, 92 smoker s melanosis, Oral submucous fibrosis, 93 Oral ulcers Behҫet s disease, pemphigus vulgaris, recurrent aphthous stomatitis, 97 Oropharyngeal cancer, 94, 95 P Palmar/plantar melanotic macules, 81 Pansclerotic morphea, 182 Papillary dermis, 42 Papulosquamous disorders lichen planus, 299 pityriasis rosea, psoriasis, 298 Patterned pigmentation,
9 Index 487 linear nevoid hypomelanosis vs. LWNH, 289 pigmentary demarcation lines, 289 transient infantile patterned hyperpigmentation, 289 Pediatric dermatology acneiform eruptions acne vulgaris, 300 periorificial dermatitis, 300 birthmarks café-au-lait macules, 288 dermal melanocytosis, patterned pigmentation, dermatitis allergic contact dermatitis, 297 atopic dermatitis, 295, seborrheic dermatitis, hair disorders piedra, 302 tinea capitis, traction alopecia, 301 trichorrhexis nodosa, 301 late-onset and secondary hyperpigmentation Becker s nevus, 291 friction hypermelanosis, 292 idiopathic eruptive macular pigmentation, 292 postinflammatory hyperpigmentation, 292 reticulate hyperpigmentation, 293 later onset hypopigmentation and depigmentation clear cell papulosis, pityriasis alba, 294 postinflammatory hypopigmentation and depigmentation, 293 progressive macular hypomelanosis, 294 vitiligo, newborns, vesicular and pustular diseases in infantile acropustulosis, 303 transient neonatal pustular melanosis, 303 papulosquamous disorders lichen planus, 299 pityriasis rosea, psoriasis, 298 pediatric malignancies, pigmented nevi congenital melanocytic nevi, 291 nail matrix, melanonychia and nevi of, 290 Pediatric malignancies, Peeling agents alpha-hydroxy acids glycolic acid, lactic acid, 441 mandelic acid, 441 phytic acid, pyruvic acid, 442 beta-hydroxy acids b-lipohydroxy acid, salicylic acid, Jessner s solution, retinoids, 445 trichloroacetic acid, 444 Pemphigus vulgaris, People of color (POC), 257 Periorbital hyperpigmentation (POH), , definition/clinical presentation, 77 etiology, 78 treatment, 78 Periorificial dermatitis, 300 Persistent pigment darkening (PPD), 54 Photoaging, 409 Photodermatoses, Phototherapy, 135 Physiologic longitudinal melanonychia, Physiologic pigmentation acquired idiopathic pattern facial pigmentation, 79 genitals, melanotic macules of, 80 newborn, oral mucosal hyperpigmentation mucosal melanosis, oral melanotic macules, 80 treatment of, 80 palmar/plantar melanotic macules, 81 pigmentary demarcation lines clinical course and treatment, 77 clinical presentation, 76 epidemiology, 76 etiology, 77 periorbital hyperpigmentation definition and clinical presentation, 77 etiology, 78 treatment, 78 physiologic longitudinal melanonychia, Phytic acid, Phytophotodermatitis, 56 Piebaldism, 223 Piedra, 302 Pigmentary demarcation lines (PDLs) clinical presentation, 76
10 488 Index Pigmentary demarcation lines (PDLs) (cont.) epidemiology, 76 etiology, 77 clinical course and treatment, 77 Pigmentary mosaicism. See Patterned pigmentation Pigmentation, disorders of. See also Skin pigmentation melasma, vitiligo, Pigmented nevi congenital melanocytic nevi, 291 nail matrix, melanonychia and nevi of, 290 Pityriasis alba (PA), , 294 Pityriasis rosea (PR), Pityriasis versicolor. See Tinea versicolor (TV) Pityrosporum ovale, 215 Platelet-rich plasma (PRP), 339 Polymethylmethacrylate (PMMA), 114 Pomade acne, 300 Post-inflammatory hyperpigmentation (PIH), 18 19, 81, 92, 104, 292, 406, 418 acne with, 105f diagnosis and clinical presentation, 198 etiology, histology, 199 management, 199 Post-inflammatory hypopigmentation (PIHypo), Potassium hydroxide (KOH), 216 Potassium-titanyl-phosphate (KTP), 407 p-phenylenediamine (PPD), 297 Pre-vitamin D 3, 5 Progressive macular hypomelanosis (PMH), , 294 Prominent mandible, Proopiomelanocortin (POMC), 52 Prophylactic therapy, 216 Propionibacterium acnes, 104 Protein-esterified ceramides, 68 Provitamin D 3, 41 Pseudofolliculitis barbae (PB) clinical features, epidemiology, 359 pathophysiology, 360 treatment, Pseudofolliculitis barbae (PFB), 238, Psoriasis clinical manifestations, epidemiology, 132 histopathology, 135 papulosquamous disorders, 298 pathophysiology, 133 treatment, 135 Psoriatic arthritis, 134 Pulsed dye lasers (PDL), 202, , Pustular psoriasis, 133 Pyruvic acid, 442 Q QS alexandrite lasers (QSAL), 454 Q-switched lasers, 199 Quality of life (QOL), 14 Quality-switched (QS) lasers, 399 R Raynaud s phenomenon, 177 Reactive oxygen species (ROS), 3, 51 Recurrent aphthous stomatitis (RAS), 97 Resorcinol, 376 Reticulate hyperpigmentation, 293 Retinoid dermatitis, 106 Retinoids, 106, 445 Rimabotulinumtoxin B, 398 Rosacea azelaic acid, 117 brimonidine gel, 122 calcineurin inhibitors, 122 chronic inflammatory disorder, 114 clinical manifestations of, 115 clinical trials, 117 differential diagnosis of, 116 extrafacial sites of, 115 FACE syndrome, 117 general facial skin care recommendations for, 117 granulomatous rosacea, 116 ivermectin, 122 oral antibiotic, 123 oral pharmacologic agents, 123 post-inflammatory hypopigmentation, 116, 116f prevalence of, 114 rebound erythema, 122 subtypes of, 115 topical metronidazole, 117 Ruby laser, S Salicylic acid (SA), Salt and pepper sign, 175 Sarcoidosis, clinical features, diagnostic workup and histology, incidence, 184 morbidity and mortality, 188 multisystem inflammatory disorder, 183
11 Index 489 pathogenesis, treatment, Sarcoidosis Health Questionnaire (SHQ), 22 Scalp microbiome, 324 Scarring alopecias, 147 central centrifugal cicatricial alopecia clinical, 341 differential diagnoses, 342 etiology of, 340 hot comb alopecia, 340 pathogenesis, 340 systemic anti-inflammatory agents, 342 treatment of, 342 chronic cutaneous DLE, lichen planopilaris, 349 neutrophilic scarring alopecias, traction alopecia behavioral modification, 345 clinical, 343 dermoscopic findings, 344 differential diagnoses for, frontal alopecia, 344 histopathology, 344 risk of, 343 treatment of, 345 Scleroderma. See Systemic sclerosis (SSc) Sebaceous glands, 44 Seborrheic dermatitis (SD), 148, Seborrheic keratoses, 392 Selenium sulfide, 216 Senile angioma. See Cherry angioma Sentinel lymph node biopsy (SLNB), 268 Silicone gel dressings, 411 Silicone gel sheets (SGS), Simple aphthosis, 97 Skin aging, features of age-associated pigmentary changes, facial volume and structure, changes in, intrinsic and extrinsic aging, photoaging, 391 photoprotection and aging prevention chemical peels, 398 dermal fillers, 397 intense pulse light, 399 melanin protection, 396 neuromodulators, QS lasers, 399 side effects and treatment considerations, physiologic and structural properties of, 390 Skin barrier, 67 Skin biopsies, 138 dermatomyositis, 180 Skin cancer basal cell carcinoma clinical presentation, 263 pathogenesis, 262 pathology, treatment, 264 cutaneous lymphoma B-cell lymphoma (CBCL), 272 hypopigmented mycosis fungoides, 271, 272f mycosis fungoides, 270, 271 non-hodgkin lymphomas, 270 T-cell lymphoma (CTCL), 270 dermatofibrosarcoma protuberans, hypothesis, 2 Kaposi s sarcoma AIDS-related, 273 classic and endemic, 273 clinical presentation of, 272 HHV-8 infection, 273 historical, transplantation-related, 273 treatment of, 275 types, 273 Merkel cell carcinoma, melanoma clinical presentation, incidence, 264 pathogenesis and risk factors, 265 treatment and prognosis, non-melanoma skin cancer, 258 squamous cell carcinoma clinical presentation, pathogenesis, 259 treatment, 261 Skin disease pigmentation, disorders of melasma, vitiligo, sarcoidosis, Skin of color acne, pathogenesis of, 104 dermatomyositis clinical presentation, diagnosis of, 179 epidemiology, 178 histology, 180 pathogenesis, prognosis and mortality, 180 treatment, morphea
12 490 Index clinical presentation, histology, 182 prevalence in, 181 treatment, 183 mucosal lesions in.(see Mucosal lesions) naked skin, evolution of, 1 3 sarcoidosis clinical features, diagnostic workup and histology, incidence, 184 morbidity and mortality, 188 multisystem inflammatory disorder, 183 pathogenesis, treatment, skin aging. (See Skin aging) skin pigmentation concept of, 6 8 folate, photosensitivity of, 3 Homo sapiens, 4 6 primary role of, 3 skin cancer hypothesis, 2 3 UVR, 2 systemic lupus erythematosus CLE, epidemiology of, 162 clinical presentation, diagnosis of, 163 disease severity, epidemiology of, 168 histology of, 167 immunopathologic features of, 167 pathogenesis, survival and mortality, treatment, systemic sclerosis cutaneous and systemic features, diagnosis of, 174 disease severity and mortality, epidemiology of, 173 histology, 175 pathogenesis, serologic markers in, 176 treatment, 177 tinea capitis.(see Tinea capitis (TC)) tinea nigra. (See Tinea nigra) tinea versicolor. (See Tinea versicolor (TV)) Skin phototype system (SPS), 53 Skin pigmentation color-based race, concept of, 6 8 folate, photosensitivity of, 3 Homo sapiens MC1R gene, 5 melanin dust, 4 pre-vitamin D3, 5 skin color phenotypes, 6 UVB than UVA, 4 primary role of, 3 skin cancer hypothesis, 2 3 UVR, 2 Skindex 29, questionnaire, 14 Smoker s melanosis (SM), Socioeconomic status (SES), 470 Sodium lauryl sulfate (SLS), 30 Solar lentigines, 395 Soy, 425 Squamous cell carcinoma (SCC), 94 95, 258 clinical presentation, pathogenesis, 259 treatment, 261 Staphylococcus epidermidis., 112 Steroid-sparing agents, 181 Stratum corneum (SC), 27 architecture of, black and white skin, differences of, 36, 37t ceramides, 38 compartments, 36 factors influencing, 70 homeostatic biochemical barrier, lipid composition of, 36 lipid-rich membrane, 36 skin irritation, 37 skin ph, 38 transepidermal water loss, water content, 38 water-holding capacity.(see Water-holding capacity) Striae distensae (SD), 411 Subacute cutaneous lupus erythematosus (SCLE), 164 Subcutis, 43 Submucous fibrosis, 93 Sun protection factor (SPF), 40, 55, 58 Superficial spreading melanoma (SSM), 266 Surveillance, epidemiology, and end results (SEER), 264 Systemic glucocorticoids, 183 Systemic lupus activity measure (SLAM), 169 Systemic lupus erythematosus (SLE) cutaneous lupus erythematosus, epidemiology of, 162 clinical presentation acute cutaneous lupus erythematosus, 164 categories, 163 chronic cutaneous lupus erythematosus, 164
13 Index 491 chilblain lupus, 167 discoid lupus erythematosus lesion, 166 lupus panniculitis, 167 photosensitivity, 164 subacute cutaneous lupus erythematosus, 164 subcategories, 163 disease severity Africans and African Americans, Asians, Hispanics, 169 diagnosis of, 163 epidemiology of, 168 histology of, 167 immunopathologic features of, 167 pathogenesis, survival and mortality, treatment, Systemic sclerosis (SSc) cutaneous and systemic features, diagnosis of, 174 disease severity and mortality, epidemiology of, 173 histology, 175 pathogenesis, serologic markers in, 176 treatment, 177 Systemic therapy, 149 T Telogen effluvium (TE), 335 Terbinafine, 149, 216 Thermal relaxation time (TRT), 452 Thiopurine methyltransferase (TPMT), 132 Thyroid transcription factor 1 (TTF-1), 278 Tinea capitis (TC), clinical presentation black dot, 146 diffuse pustular, 146 diffuse scale, 146 favus, 146 gray patch, 146 inflammatory variants, 147 kerion, 146 scarring alopecia, 147 differential diagnosis, 148 epidemiology, 144 fungal infection, 143 pathogenesis, 145 treatment, workup/diagnosis culture, 147 dermoscopy, 148 microscopy, 147 pathology, 148 wood s lamp, 147 Tinea nigra, Tinea versicolor (TV) clinical features, diagnosis, 153 differential diagnosis, 153 epidemiology, hypopigmentation and depigmentation, pathogenesis and etiology, treatment antifungal agents, 155 ketoconazole, 154 oral medications, 154, 154t prophylactic regimens for, 155t spectrum antifungal medication, 154 Tongue cancer, 95 Topical therapies, hyperpigmentation arbutin, 425 ascorbic acid, 425 azelaic acid, chemical sunscreens, 419 combination therapy, 423 emerging topical agents, FDA-approved sunscreen ingredients, 419, 419t hydroquinone, kojic acid, licorice, mequinol, 424 N-acetyl glucosamine, 426 niacinamide, 426 retinoids, soy, 425 sun protection factor, 418 strengths and weaknesses, 420t Traction alopecia (TA), 301 behavioral modification, 345 clinical, 343 dermoscopic findings, 344 differential diagnoses for, frontal alopecia, 344 histopathology, 344 risk of, 343 treatment of, 345 Transepidermal water loss (TEWL), 28, 29, 36 37, 63 Transforming growth factor-b (TGF-b), 238 Transforming growth factor b1 (TGF-b1), 173 Transient neonatal pustular melanosis (TNPM), 303 Tretinoin, 199
14 492 Index Trichloroacetic acid (TCA), 444 Tricholosporum violaceum, 145 Trichophyton schoenleinii, 145 Trichophyton tonsurans, 143, 145 Trichorrhexis nodosa, 301 Trichrome vitiligo, 293 Tuberous sclerosis, 223 U Ultraviolet radiation (UVR), 201 biological effects of UVA, UVB, 52 clinical effects of, Ultraviolet (UV) rays, 40. See also Ultraviolet radiation (UVR) Unwanted hair, UVA darker skin types, 51 erythema, 54 photoaging, pigmentation, 54 UVA protection factor (UVAPF), 55 UVB darker skin, erythema, 55 pigmentation, V Varicosities, Vascular endothelial growth factor (VEGF), 338 Visible light (VL), 53 erythema and pigmentation, 56 ultraviolet radiation, biological effects of, 53 Vitamin D, 41, 396 Vitamin D 3, 4 Vitiligo, 15 17, 223, , Vogt-Koyanagi-Harada syndrome, 223 Voight s lines, 289 Volar melanotic macules, 81 W Waardenburg syndrome, 223 Water-holding capacity corneocyte arrangement, 69 factors influencing, 70 intercellular lipids, natural moisturizing factor, 70 Wickham s striae, 136 X Xerosis, 218 Y Yeast, 143, 151, 153, 216 Z Zinc, 372 Zinc-finger neural crest transcription factor, 223 Zinc oxide (ZnO), 58, 117, 419 Zinc sulfate, 370, 371, 379 Zinc supplementation, 377
Table of Contents: Part 1 Medical Dermatology. Chapter 1 Acneiform Disorders. Acne. Acne Vulgaris. Pomade Acne. Steroid Acne
Table of Contents: Part 1 Medical Dermatology Chapter 1 Acneiform Disorders Acne Acne Vulgaris Pomade Acne Steroid Acne Infantile Acne Pediatric Perspectives Neonatal Acne (Acne Neonatorum) Pediatric Perspectives
More informationDutasteride female pattern hair loss management 49, 50 male baldness management 41, 42 Dyeing, see Hair care
Subject Index Acne keloidalis nuchae, ethnic patients 146, 147 Actinic keratosis, ultraviolet radiation exposure 108 Aging hair effects 4, 5 melanocyte aging 130 132 molecular mechanisms 5 7 pigment loss,
More informationIndex. derm.theclinics.com. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abatacept for DLE, 493 for SLE, 497 Ablative therapies, localized, for cutaneous T-cell lymphoma, 502 506. See also Cutaneous T-cell lymphoma,
More informationVitiligo. Vasanop Vachiramon, MD. Assistant professor Division of Dermatology, Ramathibodi Hospital
Vitiligo Vasanop Vachiramon, MD. Assistant professor Division of Dermatology, Ramathibodi Hospital Vitiligo Acquired pigmentary disorder Depigmented macules and patches Prevalence The worldwide prevalence
More informationAndrei Metelitsa, MD, FRCPC, FAAD Co-Director, Institute for Skin Advancement Clinical Associate Professor, Dermatology University of Calgary, Canada
Andrei Metelitsa, MD, FRCPC, FAAD Co-Director, Institute for Skin Advancement Clinical Associate Professor, Dermatology University of Calgary, Canada Copyright 2017 by Sea Courses Inc. All rights reserved.
More informationpost-peeling care and complications, 67 side effects, 68
A Acne deep peels, 102 medium, 102 superficial, 101 102 technique, 101 definition, 95 diagnosis lesions, 100 mimic rosacea, 99 100 perioral dermatitis, 99 sebaceous hyperplasia, 99 epidemiology, 95 pathogenesis
More informationIndex. B Becker s nevus, 31 Bedbugs, Black dot tinea, 116 Border hyperpigmentation, 39 Branny scale, 78 Buschke-Fischer-Brauer disease, 66
Index A Acanthosis nigricans, 127 Acneiform illnesses acne keloidalis nuchae, 20 acne scarred, 17 acne vulgaris, 15 16 Crohn s disease, 17 cystic acne, 17 hidradenitis suppurativa, 17 19 infantile acropustulosis,
More informationJUST SEE ME! PIGMENTATION SOLUTIONS FOR HIGHER FITZPATRICKS
1 2 3 JUST SEE ME! PIGMENTATION SOLUTIONS FOR HIGHER FITZPATRICKS Just See Me! Diversity AESTHETICS Training! 20+ years! Advanced Aesthetics Diversity Consultant and Trainer! Professional Speaker! Aesthetic
More informationCutanous Manifestation of Lupus Erythematosus. Presented By: Dr. Naif S. Al Shahrani Salman Bin Abdaziz university
Cutanous Manifestation of Lupus Erythematosus Presented By: Dr. Naif S. Al Shahrani Salman Bin Abdaziz university A 50-year old lady, who is otherwise healthy, presented to the dermatology clinic with
More informationIndex. Erythematotelangiectatic rosacea (ETR), Espana, A., 204
A Acne excoriee, 21, 22 Acneiform disorders, 340 Acne keloidalis nuchae (AKN), 340 description, 130 diagnosis, 131, 132 differential diagnosis, 133 epidemiology, 130 131 histopathology, 133 laser hair
More informationالاكزيماتيد= Eczematid
1 / 7 2 / 7 Pityriasis Debate confusing of hypopigmentation characterized increasing surrounded differ hypomelanotic "progressive exists alba misnomer extensive a to observed term the applied term derived
More informationIndex. derm.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A AA. See Alopecia areata. Acrofacial vitiligo presentation of, 135, 136 AD. See Atopic dermatitis. Adaptive immunity and vitiligo, 258
More informationEmergent and Urgent Dermatology, Eruptions, and Wound Care
Emergent and Urgent Dermatology, Eruptions, and Wound Care G. Scott Drew, DO, FAAD, FAOCD Smith Clinic Department of Dermatology Tucson Osteopathic Medical Foundation April 27, 2018 Acute Cutaneous Lupus
More informationIndex. Angiosarcoma diagnosis, 47 lymphedema-related vs. non-lymphedemarelated, 48
A Acneiform rash biopsy, 134 cetuximab, EGFR, 132 133 diagnosis, 131 patient history, 131 134 treatment, 134 135 Acne vulgaris, 109 AGA. See Androgenetic alopecia Alopecia areata, 148 American Joint Committee
More informationDermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.
Squamous cell carcinoma (SCC): A common malignant tumor of keratinocytes arising in the epidermis, usually from a precancerous condition: 1- UV induced actinic keratosis, usually of low grade malignancy.
More informationPart I Biology of Normal Skin, Hair and Nails
Contents Part I Biology of Normal Skin, Hair and Nails 1 Development and Biology of East Asian Skin, Hair, and Nails... 3 Mark Jean-Aan Koh 2 Developmental Biology of Black Skin, Hair, and Nails... 11
More informationExfoliation. Renew and Re-youth With. Illuminate Individuality: Acne Fall Color Preview. and Skin of Color.
www.skininc.com SEPTEMBER 2014 SEPTEMBER 2014 Illuminate Individuality: 2014 Fall Color Preview Acne and Skin of Color Renew and Re-youth With Exfoliation Treating Acne in By Jennifer Linder, MD Skin of
More informationDESCRIPTIONS FOR MED 3 ROTATIONS Dermatology A3S
Regardless of your future field of practice, you will be exposed to a considerable amount of dermatology and this rotation provides you the chance to see a range of skin diseases. You will have the opportunity
More informationSubspecialty Rotation: Dermatology
Subspecialty Rotation: Dermatology Faculty: Wesley Galen, M.D. GOAL: Prevention, Counseling and Screening (Dermatology). Understand the pediatrician's role in preventing illness and dysfunction related
More informationTips on Evaluation and Diagnosis of Scarring Alopecias. Melissa Peck Piliang, MD Dermatology and Anatomic Pathology Cleveland Clinic
Tips on Evaluation and Diagnosis of Scarring Alopecias Melissa Peck Piliang, MD Dermatology and Anatomic Pathology Cleveland Clinic Disclosures I do not have any relevant relationships with industry Investigator:
More informationContents. QAaptm-2. CAaptei-3. CAaptm-4. Cftapte%-5. Qfiaptvt-6. QhapteK-7. Qkaptefc-8 Clinical Immunology and Allergy 71
Contents Ckaptm-1 Aaatomy, Physiology, Embryology, Bacteriology and Pathology ~ 1 Anatomy 1 Physiology 10 Embryology 14 Pathology 19 Bacteriology 22 Laboratory and other aids in dermatological pratice
More informationThe Integumentary System. Mosby items and derived items 2010, 2006, 2002, 1997, 1992 by Mosby, Inc., an affiliate of Elsevier Inc.
The Integumentary System The Skin Structure two primary layers called epidermis and dermis Epidermis Outermost and thinnest primary layer of skin Composed of several layers of stratified squamous epithelium
More informationIndex. derm.theclinics.com. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abnormal wound healing Acne and cybereducation, 131 and Google, 129 131 and online dangers, 131, 132 reliable online resources on, 130 self-proclaimed
More informationThe A To Z Of Skincare Ingredients
The A To Z Of Skincare Ingredients And How They Work On The Skin With A Focus On Melanogenesis Candace Noonan, LE November 2015 Candace Noonan is a Licensed Esthetician, True U Certified Educator and Master
More informationLENTIGO SIMPLEX. Epidemiology
LENTIGO SIMPLEX Epidemiology The frequency of lentigo simplex in children and adults has not been determined. There does not appear to be a racial or gender predilection. Lentigo simplex is the most common
More informationChapter 8 Skin Disorders and Diseases
Chapter 8 Skin Disorders and Diseases Attitude is more important than the past, than education, than money, than circumstances, than what people do or say. It is more important than appearance, giftedness,
More informationLow-fluence Q-switched neodymium-doped yttrium aluminum garnet (1064nm) laser for the treatment of facial melasma in local population
Original Article Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1064nm) laser for the treatment of facial melasma in local population Tahir Kamal, Usma Iftikhar* Department of Dermatology,
More informationPATHOLOGICAL TYPES OF SCARS AND THEIR IMPACT ON TREATMENT. Dr. Tarek Ahmed Said Professor of Plastic Surgery Cairo University 2015
PATHOLOGICAL TYPES OF SCARS AND THEIR IMPACT ON TREATMENT Dr. Tarek Ahmed Said Professor of Plastic Surgery Cairo University 2015 Pathological Types of Scars Atrophic Scars Normotrophic Scars Hypertrophic
More informationDermatology GP Referral Guidelines
Austin Health Dermatology Department holds 5 Clinic sessions to discuss and plan the treatment of with Dermatology conditions. Department of Health clinical urgency categories for specialist clinics Urgent:
More informationCONDITIONS OF THE SKIN
CONDITIONS OF THE SKIN UCSF/SFGH Family & Community Medicine Residency Program Educational Objectives I. Knowledge The resident will be able to discuss the definition, diagnosis, and initial management
More informationHyperpigmentation my approach. Dr. Peter Velthuis Dermatologist Erasmus Medical Centre, Rotterdam
Hyperpigmentation my approach Dr. Peter Velthuis Dermatologist Erasmus Medical Centre, Rotterdam Conflicts of interests Consultant at Philips NV Consultant at SkinCeuticals Trainer at Allergan Hyperpigmentation,
More informationFacial Rash. Facial Rash 10/14/2013. Ten Look Alike Rashes Michelle DiBaise, MPAS, PA-C, DFAAPA Associate Clinical Professor NAU PA Program
Ten Look Alike Rashes Michelle DiBaise, MPAS, PA-C, DFAAPA Associate Clinical Professor NAU PA Program Facial Rash Facial Rash Case 1 28 year female Progressive development of erythematous facial lesions
More informationPigmented lesions of the Oral cavity
Oral medicine أ.م.د احسان عبد هللا كميل Pigmented lesions of the Oral cavity Pigmented oral lesions are a large group of disorders in which the dark or brown color is the essential clinical characteristic.
More informationLearning Objectives. Tanning. The Skin. Classic Features. Sun Reactive Skin Type Classification. Skin Cancers: Preventing, Screening and Treating
Learning Objectives Skin Cancers: Preventing, Screening and Treating Robert A. Baldor, MD, FAAFP Professor, Family Medicine & Community Health University of Massachusetts Medical School Distinguish the
More informationDERMCASE. Doc, my baby s all spotty! Case 1
Test Your Knowledge With Multiple-Choice Cases This month 5 cases: Case 1 1. Doc, my baby s all spotty! 2. A Mediterranean Matter 3. Mommy, what s wrong with my head? 4. Armed with Lesions 5. It s spreading!
More informationWR SKIN. DERMATOLOGY
WR SKIN. DERMATOLOGY 1 Societies 11 History 13 Dictionaries. Encyclopaedias. Bibliographies Use for general works only. Classify with specific aspect 15 Classification. Nomenclature 16 Tables. Statistics
More informationDermatological Manifestations in the Elderly. Sanjay Siddha Staff Dermatologist UHN & MSH
Dermatological Manifestations in the Elderly Sanjay Siddha Staff Dermatologist UHN & MSH Disclosure No actual or potential conflicts of interest or commercial relationships to declare Objectives Recognize
More informationTreatments used Topical including cleansers and moisturizer Oral medications:
Discipline: Dermatology Extended Topic: Acne & Rosacea : Onset: Location: Face Chest Back Menses if female: Regular Irregular PCOS Treatments used Topical including cleansers and moisturizer Oral medications:
More informationRash Decisions Approach to the patient with a skin condition
National Conference for Nurse Practitioners April 25, 2014 Rash Decisions Approach to the patient with a skin condition Margaret A. Bobonich, DNP, FNP C, DCNP, FAANP Assistant Professor, Case Western Reserve
More informationPeeling. Smooth out the skin. Remove the outer skin layers. Erase the fine wrinkles. The regenerated skin is smoother & Less wrinkled - Renewed
If you foolishly ignore beauty, you will soon find yourself without it. Your life will be impoverished. But if you wisely invest in beauty, it will remain with you all the days of your life Frank Lloyd
More informationSkin Deep: Cutaneous Lupus. Dr Sarah Sasson Immunology Registrar, Liverpool Hospital 2016
Skin Deep: Cutaneous Lupus Dr Sarah Sasson Immunology Registrar, Liverpool Hospital 2016 Introduction: Cutaneous lupus erythematosus LE is an autoimmune disease with a range of clinical manifestations
More information4) OCA4. 5) Hermansky-Pudlak syndrome (HPS) 6) Chédiak-Higashi syndrome (CHS) 2. Vitiligo vulgaris. To Order, Visit the Purchasing Page for Details
Go Back to the Top To Order, Visit the Purchasing Page for Details 4) OCA4 OCA4 is caused by abnormality in the membrane-associated transporter protein (MATP). OCA4 is mainly seen in patients of African
More informationPROCEEDINGS PRACTICAL APPLICATIONS: CASE STUDY REVIEWS* Bernard A. Cohen, MD, FAAP
PRACTICAL APPLICATIONS: CASE STUDY REVIEWS* Bernard A. Cohen, MD, FAAP A HEALTHY 4-WEEK-OLD INFANT WITH ACNE A 4-week-old infant was brought to the pediatrician s office by his parents following the appearance
More informationIntegumentary System
Integumentary System The integumentary system is commonly known as the Skin Largest organ of human body 10% total body weight and would cover over 20 square feet Functions of Skin 1. Protection Barrier
More informationOMICS International Conferences
About OMICS Group OMICS Group is an amalgamation of Open Access Publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information
More informationTest your knowledge with multiple-choice cases. What are these speckled spots?
Test your knowledge with multiple-choice cases Case 1 What are these speckled spots? A speckled, pigmented lesion is noticed on the upper arm of a 10-year-old girl. Her mother says the lesion has been
More informationIT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY
IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY Skin, Bones, and other Private Parts Symposium Dermatology Lectures by Debra Shelby, PhD, DNP, FNP-BC, FADNP, FAANP Debra Shelby,
More informationBRAND SPECIALISING IN THE TREATMENT OF DARK SPOTS
2 Offers dermatologists, practitioners and beauty professionals a wide range of depigmentation products, providing treatments uniquely formulated according to the type of hyperpigmentation, skin type and
More informationNew Patient Hair Loss: Now What? Melissa Piliang, MD Cleveland Clinic Dermatology and Pathology
New Patient Hair Loss: Now What? Melissa Piliang, MD Cleveland Clinic Dermatology and Pathology Conflict of Interest No relevant conflicts Investigator for Samumed, Kythera, Incyte, Concert, Allergan Advisory
More informationACTIVE.LITE. Patent-Pending Technology + Visibly Perceivable Results in Less than 14 Days. Tomorrow s Vision Today!
ACTIVE.LITE Patent-Pending Technology + Visibly Perceivable Results in Less than 14 Days Tomorrow s Vision Today! AESTHETIC PERFECTION IS THE STANDARD Aesthetic skin perfection is now the consumer standard
More informationPoonkiat Suchonwanit, MD Hair and Scalp Disorders Unit Division of Dermatology Department of Medicine Ramathibodi Hospital
Poonkiat Suchonwanit, MD Hair and Scalp Disorders Unit Division of Dermatology Department of Medicine Ramathibodi Hospital Hair loss Excessive hair growth Hair haft abnormalities Hair color Anagen Catagen
More informationThis section covers the basic knowledge of normal skin structure and function required to help understand how skin diseases occur.
Background Knowledge Functions of normal skin Background Knowledge This section covers the basic knowledge of normal skin structure and function required to help understand how skin diseases occur. Learning
More informationCutaneous Malignancies: A Primer COPYRIGHT. Marissa Heller, M.D.
Cutaneous Malignancies: A Primer Marissa Heller, M.D. Associate Director of Dermatologic Surgery Department of Dermatology Beth Israel Deaconess Medical Center December 10, 2016 Skin Cancer Non-melanoma
More informationFacial hyperpigmentation: causes and treatment N.A. Vashi 1 and R.V. Kundu 2
REVIEW ARTICLE Facial hyperpigmentation: causes and treatment N.A. Vashi 1 and R.V. Kundu 2 BJD British Journal of Dermatology 1 Department of Dermatology, Boston University School of Medicine, Boston
More informationStaying A- Head in Pediatric Dermatology:
Staying A- Head in Pediatric Dermatology: Common Scalp and Hair Diagnoses Matt Grisham, MD Greenville Health System Post-Graduate Seminar April 20, 2016 I have no financial disclosures or conflicts of
More informationCOSMELAN DEPIGMENTATION TREATMENT
DEPIGMENTATION TREATMENT The Cosmelan method has been designed to attenuate/eliminate darkened skin spots of melanic origin. This unaesthetic but frequent problem has different origins. Among them: Genetics
More informationb) SKILLS The student should be able to
1. GOAL The aim of teaching the undergraduate student in Dermatology, S.T.D. and Leprology is to impart such knowledge and skills that may enable him to diagnose and treat common ailments and to refer
More informationIdentifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018
Identifying Skin Cancer Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018 American Cancer Society web site Skin Cancer Melanoma Non-Melanoma
More informationHypopigmenting agents
An in-depth review on the biological and chemical aspects of hyperpigmentation and contemporary strategies for achieving even skin tone Hypopigmenting agents Melanin Pigment that provides color to skin,
More informationSubject Index. Dry desquamation, see Skin reactions, radiotherapy
Subject Index Actinic keratosis disseminated disease 42 surgical excision 42 AIDS, see Kaposi s sarcoma Amifostine, skin reaction prophylaxis 111 Basal cell carcinoma, superficial X-ray therapy Bowen s
More informationDermatology Pearls. Leah Layman, ARNP Jefferson Healthcare Dermatology June 21, 2018
Dermatology Pearls Leah Layman, ARNP Jefferson Healthcare Dermatology June 21, 2018 What s on the agenda? Common skin conditions and where to start with treatment Gentle skin care regimen PCP and Biologics
More informationEvidence-based Clinical Practice Guidelines for Treatment of Acne and Rosacea in Canada. Catherine Zip Nov 10, 2016
Evidence-based Clinical Practice Guidelines for Treatment of Acne and Rosacea in Canada Catherine Zip Nov 10, 2016 Acne Acne Classification Type Comedonal Mild-to-moderate papulopustular acne Severe Description
More informationReports on Scientific Meeting
Hong Kong J. Dermatol. Venereol. (2005) 13, 102-106 63rd Annual Meeting, American Academy of Dermatology Reported by LS Chiu Date: 22 February, 2005 Venue: New Orleans, Louisiana, USA Organiser: American
More information9/9/17. Disclosures" Dermatology in Primary Care: Recognition and treatment of common disorders of the skin" A preview" Classic skin infections"
Disclosures Dermatology in Primary Care: Recognition and treatment of common disorders of the skin I have no conflicts of interest to disclose. I may discuss off-label use of treatments for cutaneous disease.
More informationTime to Learn. 6 th March 2018 Dr. Shirin Chakera GPwSI Integrated Dermatology Service
Time to Learn 6 th March 2018 Dr. Shirin Chakera GPwSI Integrated Dermatology Service The Red Face Rosacea Acne Seborrhoeic eczema eczema Psoriasis Slapped cheek syndrome Fungal infection Erysipelas...
More informationSkin Disorders of the Nose in Dogs
Customer Name, Street Address, City, State, Zip code Phone number, Alt. phone number, Fax number, e-mail address, web site Skin Disorders of the Nose in Dogs (Canine Nasal Dermatoses) Basics OVERVIEW Conditions
More informationCH 05 THE INTEGUMENTARY SYSTEM
CH 05 THE INTEGUMENTARY SYSTEM This system consists of skin and its derivatives. The skin is one of the largest organs of the body in terms of surface area. The functions of the integumentary system include:
More information4. Pityriasis lichenoides
Go Back to the Top To Order, Visit the Purchasing Page for Details usually more than 5 cm in diameter and accompanied by poikiloderma. Some but not all patients may develop mycosis fungoides (Fig. 22.35).
More informationDERMATOLOGY ROTATION: COMPETENCY-BASED GOALS AND OBJECTIVES
UNC DIVISION OF PLASTIC AND RECONSTRUCTIVE SURGERY DERMATOLOGY ROTATION: COMPETENCY-BASED GOALS AND OBJECTIVES MEDICAL KNOWLEDGE A. Anatomy/Physiology/Embryology Goal: The resident will have knowledge
More informationIntroduction. Skin and Body Membranes. Cutaneous Membranes Skin 9/14/2017. Classification of Body Membranes. Classification of Body Membranes
Introduction Skin and Body Membranes Body membranes Cover surfaces Line body cavities Form protective and lubricating sheets around organs Classified in 5 categories Epithelial membranes 3 types- cutaneous,
More informationNO MORE NEWS AN EVIDENCE BASED APPROACH ON LASERS IN SKIN OF COLOR PATIENTS DR. EDUARDO WEISS, M.D., FAAD
NO MORE NEWS AN EVIDENCE BASED APPROACH ON LASERS IN SKIN OF COLOR PATIENTS DR. EDUARDO WEISS, M.D., FAAD KEY POINTS Hispanics/Latinos are the fastest growing segment of the skin of color population Use
More informationIntegumentary System-Skin and Body Coverings
Integumentary System-Skin and Body Coverings List the four types of epithelial or connective membranes. The epithelial cutaneous includes your and is exposed to the. Its function is to. An example is..
More informationPrinciples of Anatomy and Physiology
Principles of Anatomy and Physiology 14 th Edition CHAPTER 5 The Integumentary System Introduction The organs of the integumentary system include the skin and its accessory structures including hair, nails,
More informationDue next week in lab - Scientific America Article Select one article to read and complete article summary
Due in Lab 1. Skeletal System 33-34 2. Skeletal System 26 3. PreLab 6 Due next week in lab - Scientific America Article Select one article to read and complete article summary Cell Defenses and the Sunshine
More informationSkin and Body Membranes Body Membranes Function of body membranes Cover body surfaces Line body cavities Form protective sheets around organs
Skin and Body Membranes Body Membranes Function of body membranes Cover body surfaces Line body cavities Form protective sheets around organs Classification of Body Membranes Epithelial membranes Cutaneous
More informationDermatology elective for yr. 5. Natta Rajatanavin, MD. Div. of dermatology Dep. Of Medicine, Ramathibodi Hospital Mahidol University 23 rd Feb 2015
Dermatology elective for yr. 5 Natta Rajatanavin, MD. Div. of dermatology Dep. Of Medicine, Ramathibodi Hospital Mahidol University 23 rd Feb 2015 How to diagnosis and manage eczema and psoriasis. Objectives
More informationBirthmarks: When to worry, when to reassure
Birthmarks: When to worry, when to reassure Aimee Smidt, MD, FAAD, FAAP Associate Professor, Depts of Dermatology and Pediatrics University of New Mexico School of Medicine November 2016 Goals and Objectives
More informationDermoscopy: Recognizing Top Five Common In- Office Diagnoses
Dermoscopy: Recognizing Top Five Common In- Office Diagnoses Vu A. Ngo, DO Department of Family Medicine and Dermatology Choctaw Nation Health Services Authority Learning Objectives Introduction to dermoscopy
More informationTips on getting the most from your alopecia pathology reports. D irector, H a ir C linic, Boston Medical C e n ter
Tips on getting the most from your alopecia pathology reports Lynne J. Goldberg, MD J a g Bhawan Professor o f Dermatology a n d Pathology & Laboratory Medicine Boston U n iversity School of Medicine D
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adhesive tape impression 1 Diff Quik in EPD diagnosis, 583 Allergy(ies). See also Food allergy; specific types, e.g., Culicoides hypersensitivity
More informationDermatology. History: Atopies (patient and family) Lifetime sun exposure Allergies Treatment to date (self or GP)
History: Atopies (patient and family) Lifetime sun exposure Allergies Treatment to date (self or GP) Examination: Distribution over body Local patterns Individual lesion Skin types 1: Never Tans, Always
More informationSome skin conditions
Some skin conditions Some skin conditions Acute Inflammatory Dermatoses Chronic Inflammatory Dermatoses Blistering (Bullous) Diseases Panniculitis Disorders of Epidermal Appendages -Urticaria -Acute eczematous
More informationUnit 4 The Integumentary System
Unit 4 The Integumentary System I. Classification of Body Membranes A. Epithelial Membranes (3) 1. Cutaneous Membrane > Stratified Squamous > Sits on Dense Connective Tissue > Skin: Epidermis & Dermis
More informationOptions. Laser resurfacing Chemical peels Dermabrasion Topical therapy
Facial Resurfacing Options Laser resurfacing Chemical peels Dermabrasion Topical therapy Photoaging Most chronic changes occur from UVB light (290 to 320nm) associated with sunburn Ultraviolet AII (320-240nm)
More informationMEDICAL DERMATOLOGY BASIC, CORE, AND APPLIED EXAMINATIONS CONTENT OVERVIEW. First-year resident level: BASIC exam. Senior resident level: CORE exam
The descriptions below are general guidelines about content that may be evaluated in the ABD examinations. Content overlap among stages (BASIC v. CORE v. APPLIED) and specialty areas (e.g., medical v.
More informationDiagnosis and Management of the Hair Loss Patient: Pearls and Pitfalls
Diagnosis and Management of the Hair Loss Patient: Pearls and Pitfalls U033 July 30 th 2017 7:30-8:30AM Paradi Mirmirani, MD The Permanente Medical Group, Vallejo, CA Regional Director, Hair Disorders
More informationDermatologic Care of Women with Skin of Color Pearl E. Grimes, MD
Dermatologic Care of Women with Skin of Color Pearl E. Grimes, MD Director Vitiligo and Pigmentation Institute of Southern California and Clinical Professor Division of Dermatology David Geffen School
More informationDisclosures. Managing Dyschromias. Objectives. Epidemiology in Skin of Color. Epidemiology in Skin of Color. Categorization
Managing Dyschromias Fall Clinical Dermatology Conference Las Vegas, NV October 21, 2016 Disclosures No pertinent conflicts of interest in relation to this presentation Seemal R. Desai, MD, FAAD Clinical
More informationDermatology Syllabus for 5th Year Med Students
Hawler Medical University College of Medicine Department of medicine 2011-2012 Dermatology Syllabus for 5th Year Med Students Course Information: Course Title : Dermatology Credit Hours : Time Theoretical:
More informationDermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial
Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial Cutaneous Oncology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI
More informationUnit 4 - The Skin and Body Membranes 1
Unit 4 - The Skin and Body Membranes 1 I. Unit 4: Skin and Body Membranes A. Body Membranes 1. Function of body membranes a) Cover body surfaces b) Line body cavities c) Form protective sheets around organs
More informationBenign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc
1 Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc Benign lesions Seborrheic Keratoses: Warty, stuck-on Genetics and birthdays Can start in late
More informationDescribe the functions of the vertebrate integumentary system. Discuss the structure of the skin and how it relates to function.
Chapter 5 Describe the functions of the vertebrate integumentary system. Discuss the structure of the skin and how it relates to function. Explain the basis for different skin colors. Describe the structure
More informationGeneral Dermatology Objectives Learn to recognize some common dermatologic disorders d and some associated with systemic diseases Learn the causative
General Dermatology Julia R. Nunley, MD, FAAD, FACP Professor Program Director Department of Dermatology General Dermatology Objectives Learn to recognize some common dermatologic disorders d and some
More informationReports on Scientific Meeting
Hong Kong J. Dermatol. Venereol. (2014) 22, 35-40 Joint Annual Scientific Meeting 2013 Reported by Y Chan, CW Chow, SM Wong, WF Wu Date: 1 December 2013 Venue: Cheung Kung Hai Conference Centre, Li Ka
More informationCutaneous Conditions Associated with Systemic Disease
Cutaneous Conditions Associated with Systemic Disease Johnnie M Woodson, M.D., F.A.A.D. Assistant Professor of Dermatology University of Nevada School of Medicine Director of J. Woodson Dermatology & Associates,
More informationUpdate on Challenging Disorders of Pigmentation in Skin of Color
Update on Challenging Disorders of Pigmentation in Skin of Color Heather Woolery-Lloyd, M.D. Director of Ethnic Skin Care Voluntary Assistant Professor Miller/University of Miami School of Medicine Department
More information